GSE171763: Inhibitors of Bcl-2 and Bruton’s Tyrosine Kinase Synergize to Abrogate Diffuse Large B-Cell Lymphoma (DLBCL) Growth. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.